Press Release Archive

04.10.2011

Pfizer and Medivation Announce Results from Phase 3 HORIZON Trial of Dimebon in Huntington Disease

04.07.2011

Zacharon Pharmaceuticals Announces Research and Development Collaboration with Pfizer to Develop Drugs for Multiple Rare Disorders

04.05.2011

Pfizer Invites Public To View And Listen To Webcast Of May 3 Conference Call With Analysts

04.04.2011

Rigel Assumes Development Responsibility

04.04.2011

Pfizer to Sell Capsugel to KKR

04.04.2011

Pfizer and Shanghai Pharmaceutical Sign Memorandum of Understanding for Potential Strategic Partnership

04.03.2011

Pfizer Receives Refusal To File Letter From U.S. FDA On Tafamidis New Drug Application

04.03.2011

Pfizer to Sell Capsugel to KKR

03.31.2011

Pfizer Oncology To Present Broad Array Of New Pre-Clinical And Clinical Data From Early And Late Stage Compounds

03.31.2011

Pfizer Posts Details Of Interactions With U.S. Health Care Professionals And Researchers In 2010

03.26.2011

Greenstone Announces Voluntary Nationwide Recall of Citalopram and Finasteride Due to Possible Mislabeling

03.24.2011

Pfizer Animal Health Continues to Invest in the Future of Veterinarians with Announcement of 2011 Veterinary Scholarship Recipients

03.23.2011

SPIRIVA HandiHaler Prolonged Time To First COPD Exacerbation, New Study In NEJM Shows

03.09.2011

Pfizer Invites Public To View And Listen To Webcast Of Pfizer Presentation At Healthcare Conference

03.03.2011

Pfizer Announces Primary Endpoints Met In Second Phase 3 Clinical Trial Of Tofacitinib (CP-690,550) In Patients With Active Rheumatoid Arthritis

03.03.2011

Charles River Announces Agreement To Supply Pfizer’s Genetically Modified Research Models

03.01.2011

World-Class Professional Golfer Phil Mickelson Launches “On Course with Phil” for People with Certain Inflammatory Joint and Skin Conditions

03.01.2011

King Pharmaceuticals, Inc. Announces Final Results of Its Offer to Purchase Convertible Notes

02.28.2011

Pfizer Completes Acquisition Of King Pharmaceuticals, Inc.

02.28.2011

Pfizer Announces Updated, Interactive Development Pipeline

02.28.2011

XIAPEX® (Collagenase Clostridium Histolyticum) Authorized in the European Union (EU) For Dupuytren’s Contracture

02.23.2011

NH Citizens Health Initiative to Premiere Mini-Documentaries on NH Multi-Stakeholder Patient Centered Medical Home Pilot

02.22.2011

U.S. Supreme Court Decision In Bruesewitz V. Wyeth A Win For Public Health

02.10.2011

New AVERROES Data Demonstrate Investigational Apixaban Superior to Aspirin in Reducing Stroke and Systemic Embolism in Patients with Atrial Fibrillation Unsuitable for Warfarin Therapy

02.06.2011

Pfizer To Acquire Ferrosan’s Consumer Healthcare Business

02.03.2011

Enbrel® (etanercept) Significantly Improved Scalp Involvement in Patients with Moderate to Severe Plaque Psoriasis

02.03.2011

New Co-Promotion Agreements For Rheumatoid Arthritis Products In Japan

02.02.2011

National Family Caregivers Association Supports Advocate in His Mission to Raise Awareness of the Burden of Alzheimer’s Disease

01.31.2011

Pfizer Announces New $5 Billion Share Repurchase Program

01.31.2011

Pfizer Reports Fourth-Quarter and Full-Year 2010 Results; Provides 2011 Financial Guidance and Updates 2012 Financial Targets

01.31.2011

Pfizer Completes Tender Offer For Shares Of King Pharmaceuticals, Inc.

01.30.2011

Dr. Yvonne Greenstreet Joins Pfizer As Senior Vice President And Head Of Medicines Development, Specialty Care Business Unit

01.27.2011

Pfizer Chief Medical Officer Freda Lewis-Hall Named 2011 Woman Of The Year

01.27.2011

Pfizer Announces HSR Clearance for the Acquisition of King Pharmaceuticals

01.25.2011

Pfizer Inc and Progenics Alert Physicians and Patients to Information Related to Triad Group Alcohol Prep Products Included In U.S. RELISTOR Kit Packaging

01.24.2011

Pfizer Announces Seven Of New York City’s Top Research Hospitals Join Global Centers For Therapeutic Innovation

01.20.2011

Pfizer Extends Tender Offer to Acquire King Pharmaceuticals, Inc. to January 28, 2011

01.20.2011

Pfizer Inc. UK Regulatory Announcement: Pfizer Extends Tender Offer to Acquire King Pharmaceuticals, Inc. to January 28, 2011

01.11.2011

Pfizer Initiates Rolling Submission For A New Drug Application In The U.S. For Its Fast-Tracked Investigational Compound Crizotinib (PF-02341066) For Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer

01.11.2011

Pfizer Inc. UK Regulatory Announcement: Pfizer Initiates Rolling Submission For A New Drug Application In The U.S. For Its Fast-Tracked Investigational Compound Crizotinib (PF-02341066) For Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer

01.04.2011

Pfizer Invites Public to View and Listen to Webcast of February 1 Conference Call with Analysts

01.04.2011

Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference

01.03.2011

Pfizer Animal Health Completes Acquisition of Synbiotics Corporation

12.15.2010

Pfizer Extends Tender Offer To Acquire King Pharmaceuticals, Inc.

12.13.2010

Pfizer Declares A 20-Cent First-Quarter 2011 Dividend

12.13.2010

Pfizer Board of Directors Elects George A. Lorch Non-Executive Chairman

12.11.2010

Young Children In Developing World Receive Accelerated Access to Pfizer's Prevenar 13 Vaccine

12.09.2010

Pfizer Stops Clinical Trials of Thelin® and Initiates Voluntary Product Withdrawal in the Interest of Patient Safety